Point72 Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$37.2M Sell
40,400
-47,100
-54% -$47.8M 0.05% 500
2025
Q4
$94M Buy
87,500
+81,500
+1,358% +$77.9M 0.11% 198
2025
Q3
$4.58M Buy
6,000
+2,800
+88% +$2.08M 0.01% 1104
2025
Q2
$2.49M Sell
3,200
-39,900
-93% -$31M ﹤0.01% 1208
2025
Q1
$35.6M Buy
43,100
+41,800
+3,215% +$34.8M 0.08% 294
2024
Q4
$1M Buy
+1,300
New +$1.08M ﹤0.01% 1455
2022
Q3
Sell
-11,100
Closed -$3.6M 1585
2022
Q2
$3.6M Buy
+11,100
New +$3.33M 0.02% 790
2020
Q1
Sell
-300,000
Closed -$39.4M 946
2019
Q4
$39.4M Buy
+300,000
New +$34.8M 0.21% 139
2017
Q1
Sell
-1,000,000
Closed -$73.5M 894
2016
Q4
$73.5M Hold
1,000,000
0.51% 37
2016
Q3
$80.3M Hold
1,000,000
0.56% 30
2016
Q2
$78.8M Buy
+1,000,000
New +$75.3M 0.54% 30

Other funds holding LLY

Point72 Asset Management's LLY Position: Q1 2026 in Review

Point72 Asset Management increased its Eli Lilly (LLY) stake by 41% in Q1 2026, buying an estimated $28.4M and bringing the position to 95,766 shares worth $88.1M. The position accounts for 0.11% of the portfolio, ranked #198.

Point72 Asset Management first reported a position in LLY in Q4 2014 and has held it in 34 quarters since. The position peaked at $195M in Q3 2020. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Point72 Asset Management held 95,766 shares of Eli Lilly worth $88.1M as of Q1 2026.
  • Point72 Asset Management bought 28,020 Eli Lilly shares in Q1 2026, an estimated $28.4M.
  • Eli Lilly made up 0.11% of Point72 Asset Management's portfolio in Q1 2026, its #198 holding.
  • Point72 Asset Management first reported a position in Eli Lilly in Q4 2014 and has held it in 34 quarters since.
  • Point72 Asset Management's Eli Lilly position peaked at $195M in Q3 2020.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.